Newsroom

Asylia Therapeutics Newsroom

Newsroom

Asylia Therapeutics Newsroom
Asylia Therapeutics moves into Jlabs, Houston Texas

Asylia Therapeutics Moves into JLABS @TMC

Houston, Texas. June 6, 2020 – Asylia Therapeutics (“Asylia”), a Texas-based, privately held, development-stage biopharmaceutical company developing novel immune modulating therapies for cancer, autoimmune, and

Read More »
Scroll to Top